Papers by Deepak L. Bhatt
Page 4 · newest first
- Po-01-306 Decidehr: Individualized Net-Benefit Anticoagulation After Ablation or Laao for Patients With Atrial FibrillationHeart Rhythm · 2026
- OR1-5 | Bleeding Risk in Patients with Chronic Kidney Disease Receiving Cangrelor for Acute Myocardial Infarction: Results from the CAMEO RegistryJournal of the Society for Cardiovascular Angiography & Interventions · 2026
- Dual Antiplatelet Therapy Duration Based on Ischemic and Bleeding Risks After Coronary StentingJournal of the American College of Cardiology · 2019
- Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta-analysis of randomized trialsEuropean Heart Journal · 2008
- Association of Cardiovascular Disease With Respiratory DiseaseJournal of the American College of Cardiology · 2019
- Women who experience a myocardial infarction at a young age have worse outcomes compared with men: the Mass General Brigham YOUNG-MI registryEuropean Heart Journal · 2020
- Cardiovascular Toxicities of Immune Checkpoint InhibitorsJournal of the American College of Cardiology · 2019
- Effect of SGLT2 Inhibitors on Cardiovascular Outcomes Across Various Patient PopulationsJournal of the American College of Cardiology · 2023
- Alirocumab Reduces Total Nonfatal Cardiovascular and Fatal EventsJournal of the American College of Cardiology · 2018
- Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trialsEuropean Heart Journal · 2022
- Efficacy and Safety of Dual Antiplatelet Therapy After Complex PCIJournal of the American College of Cardiology · 2016
- Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trialEuropean Heart Journal · 2020
- Mechanisms of benefits of sodium-glucose cotransporter 2 inhibitors in heart failure with preserved ejection fractionEuropean Heart Journal · 2023
- 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest PainJournal of the American College of Cardiology · 2021
- Interleukin-6 and C-reactive protein prognostic value following acute coronary syndromeEuropean Heart Journal · 2026
- Relationship Between Achieved LDL-C and Saphenous Vein Graft Patency: A Post Hoc Analysis of the NEWTON-CABG CardioLink-5 StudyEuropean Journal of Preventive Cardiology · 2026
- Cardio-kidney-metabolic phenotypes determine residual cardiovascular risk after acute coronary syndromesEuropean Heart Journal Supplements · 2026
- Prediction of incident heart failure in established atherosclerotic cardiovascular disease: the SMART2-HF model.2026
- Evaluation of evolocumab on saphenous vein graft patency following coronary artery bypass graft surgery in people living with and without diabetes in the NEWTON ‐ CABG CardioLink ‐5 trialDiabetes Obesity and Metabolism · 2026
- Eicosapentaenoic acid (EPA) inhibited lipoprotein(a) [Lp(a)] oxidation and its effects on expression of oxidative stress and pro-inflammatory proteins in endothelial cellsEuropean Heart Journal · 2025
- Efficacy of sotagliflozin among older adults: a pooled analysis of SCORED and SOLOIST-WHFEuropean Heart Journal · 2025
- Lifetime prediction of incident heart failure risk in patients with established atherosclerotic cardiovascular disease: the SMART2-HF risk scoreEuropean Heart Journal · 2025
- Lower rate of ischemic events with alirocumab in patients with atherosclerotic cardiovascular disease but without prior acute ischemic eventsEuropean Heart Journal · 2025
- Atorvastatin active metabolite inhibits oxidation of Lp(a), small dense LDL and triglyceride-rich lipoproteins compared to other statins through a free radical scavenging mechanismEuropean Heart Journal · 2025
- Icosapent ethyl reduces cardiovascular risk across apolipoprotein b and fasting triglyceride rich lipoprotein levelsEuropean Heart Journal · 2025
- Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKMEuropean Heart Journal · 2025
- Acute Myocardial Infarction in an Intermediate-Risk PatientJACC Case Reports · 2026
- Can Oral Anticoagulants Be Safely Discontinued Following Atrial Fibrillation Ablation? A Systematic Review and Meta-Analysis of Reconstructed Time-to-Event DataHeart Rhythm · 2026
- Preoperative beta blocker use and postoperative ischaemic stroke risk in noncardiac surgery: a multicentre retrospective cohort studyBritish Journal of Anaesthesia · 2026
- Comparison of Limus and Paclitaxel Drug–Coated Balloons, Second-Generation or Newer Drug-Eluting Stents, and Balloon Angioplasty: A Network Meta-Analysis of Randomized Controlled TrialsCirculation Cardiovascular Interventions · 2026
- Race‐ and Ethnicity‐Specific Hospital Arrival and Emergency Medicine Service Activation Times by US State for Ischemic StrokeJournal of the American Heart Association · 2025
- Minimally Invasive Surgery Versus Open Craniotomy With Clot Evacuation After Intracerebral HemorrhageAnnals of Neurology · 2025
- Icosapent ethyl reduces CVD risk in cardiovascular-kidney-metabolic syndrome: REDUCE-IT CKMAmerican Journal of Preventive Cardiology · 2025
- Cardiovascular Outcomes with Tirzepatide versus Dulaglutide in Type 2 DiabetesNew England Journal of Medicine · 2025
- Cardiac Remodeling in Preeclampsia: A Large Language Model–Assisted Meta-Analysis and Meta-RegressionJournal of Cardiovascular Pharmacology · 2025
- Percutaneous ventricular assist devices for percutaneous coronary interventions in older patients with heart failure: a target trial emulationHeart · 2025
- Preventing the first myocardial infarction: from reaction to actionEuropean Heart Journal · 2025
- Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease?European Heart Journal · 2025
- SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and AlbuminuriaJAMA · 2025
- Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of AlbuminuriaJAMA · 2025
- Abstract 4338221: EVOLocumab Very Early after Myocardial Infarction (EVOLVE-MI): A Pragmatic Randomized Multicenter International Trial - Design and Baseline CharacteristicsCirculation · 2025
- Procedural Volume and Outcomes in Lower‐Extremity Peripheral Vascular Interventions: Insights From the NCDR Peripheral Vascular Intervention RegistryJournal of the American Heart Association · 2025
- Impact of baseline systolic blood pressure on blood pressure changes following renal denervationEuroIntervention · 2025
- Polygenic risk score for coronary artery disease across the spectrum of atherosclerotic diseaseEuropean Journal of Preventive Cardiology · 2025
- Multi-modal deep-learning troponin prediction from electrocardiograms and demographic dataEuropean Heart Journal - Digital Health · 2025
- Efficacy and safety of alirocumab in patients with established atherosclerotic vascular disease before the first cardiovascular event: Pooled analysis of phase 3 ODYSSEY studiesJournal of clinical lipidology · 2025
- A polygenic risk score for peripheral artery disease and major adverse limb eventsEuropean Heart Journal · 2025
- Statistical approaches for systematically missing covariates in individual participant data meta-analysis: insights and applications using 5 large cardiovascular trialsAmerican Journal of Epidemiology · 2025
- Common genetic variants near SLC2A2 and glycemic response to glimepiride in the GRADE comparative effectiveness clinical trial2025
- Association of Neutrophil-to-Lymphocyte Ratio With Clinical Outcomes After Percutaneous Coronary InterventionEuropean Journal of Preventive Cardiology · 2025